% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Mukama:275466,
author = {T. Mukama$^*$ and B. Srour and T. Johnson$^*$ and V.
Katzke$^*$ and R. Kaaks$^*$},
title = {{IGF}-1 and risk of morbidity and mortality from cancer,
cardiovascular diseases, and all-causes in {EPIC} -
{H}eidelberg.},
journal = {The journal of clinical endocrinology $\&$ metabolism},
volume = {108},
number = {10},
issn = {0368-1610},
address = {Oxford},
publisher = {Oxford University Press},
reportid = {DKFZ-2023-00776},
pages = {e1092-e1105},
year = {2023},
note = {#EA:C020#LA:C020# / 2023 Sep 18;108(10):e1092-e1105},
abstract = {The functional status of organs involved in IGF-1
signalling pathways such as the liver influence circulating
levels of IGF-1 and hence its relationship with risk of
chronic diseases and mortality, yet has received limited
attention.To examine the relationship between IGF-1 and risk
of morbidity and mortality from cancer, cardiovascular
diseases and all-causes, accounting for liver
function.Case-cohort design nested within EPIC-Heidelberg.
IGF-1 was measured in 7,461 stored serum samples collected
from 1994 to 1998. Median follow-up for incident mortality
events: 17.5 years.General community.The case-cohort
included a subcohort of 1,810 men and 1,890 women, in
addition to 1668 incident cases of cancer (623 breast, 577
prostate, 202 lung and 268 colorectal cancers), and 1428
cases of CVD (707 MIs and 723 strokes) and 2441 cases of
death.Higher IGF-1 levels showed direct associations with
risks of breast (1.25 $95\%$ CI: [1.06-1.47]) and prostate
(1.31 [1.09-1.57]) cancers. Restricted cubic splines plots
and models including IGF-1 as quintiles revealed a U-shaped
relationship between the biomarker and mortality. Both
participants with lowest and highest levels of IGF-1
experienced higher hazards of mortality from cancer,
cardiovascular diseases and all-causes. The U-shaped form of
the relationship persisted but was attenuated in analyses
including only participants without any indications of liver
dysfunction.This large population-based prospective study
showed that both individuals with lowest and highest levels
of circulating IGF-1 were at increased risk of deaths from
cancer, cardiovascular and all-causes. For individuals with
low IGF-1, the excess risks of death were more pronounced
among individuals with liver cancer and cirrhosis but were
also present among individuals without elevated liver
enzymes.},
keywords = {IGF-1 (Other) / cancer (Other) / cardiovascular diseases
(Other) / liver enzymes (Other) / liver function (Other) /
mortality (Other)},
cin = {C020},
ddc = {610},
cid = {I:(DE-He78)C020-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37066827},
doi = {10.1210/clinem/dgad212},
url = {https://inrepo02.dkfz.de/record/275466},
}